Device recall · February 21, 2018
Synvisc-One ¿ recall
Why: Contamination with Methylbacterium thiocyanatum
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Synvisc-One ¿ (hylan G-F 20), 6mL delivered from a 10mL syringe Product Usage: A elastoviscous high molecular weight fluid containing hylan A and hylan B polymers produced from chicken combs. Synvisc-One is administered as a single intra-articular injection. Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.
- Lots / codes
Lot Number: 7RSL021 Expiration Date: 2020-05-31
- Quantity
- 12,380 units
- Company
- Sanofi Genzyme, Cambridge, MA
- Distribution
- US Nationwide distribution(36 states)
- Initiated
- December 11, 2017 · Voluntary: Firm initiated
- Classified
- February 13, 2018
- Reported
- February 21, 2018
- Ended
- April 3, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.